There is a shortage of semaglutide, sold as Ozempic and Wegovy, likely driven by celebrities and dieters receiving the drug off label and possibly paying money out of pocket for it. Here’s what to know.
Wegovy an under-the-skin injection that showed promise in weight-loss clinical trials is the first drug approved for chronic weight management since 2014.
To better support HCPs in their efforts, Donna Ryan, MD, professor emerita at Pennington Biomedical and Robert Kushner, MD, DABOM Professor of Medicine and Medical Education at the Northwestern University Feinberg School of Medicine, in collaboration with the Academy for Continued Healthcare Learning (ACHL), have developed a clinical assessment tool to provide HCPs with a “report card” on how effective they are in achieving short- and long-term therapeutic goals for their patients along with personalized recommendations on how to address inertia through weight-centric treatment strategies.